Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

96
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Best Practices of Hind Limb Transplantation in Mice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Disruption of Bacterial Biofilms by Photothermal Energy to Overcome Antibiotic Resistant Phenotype.

Military medicine·2026
Same author

EMERGE patch, a novel electrogenic engineered material to enhance healing of severe corneal wounds.

Biomaterials·2025
Same author

Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.

JCI insight·2024
Same author

T cell responsiveness to IL-10 defines the immunomodulatory effect of costimulation blockade via anti-CD154 and impacts transplant survival.

bioRxiv : the preprint server for biology·2024
Same author

Lipid-Based Nanoparticles for RNA Delivery.

Methods in molecular biology (Clifton, N.J.)·2024

Related Experiment Video

Updated: Mar 29, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.8K

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications.

Xiomara Calderón-Colón1, Giorgio Raimondi2, Jason J Benkoski1

  • 1Research and Exploratory Development Department, The Johns Hopkins Applied Physics Laboratory.

Journal of Visualized Experiments : Jove
|December 10, 2015
PubMed
Summary

Ultra-small solid lipid nanoparticles (SLNs) show potential for intracellular targeting. These biocompatible nanoparticles were effectively taken up by human and mouse cells with no observed toxicity, indicating suitability for drug delivery.

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.6K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K

Related Experiment Videos

Last Updated: Mar 29, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

18.8K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.6K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

8.1K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cell Biology

Background:

  • Nanoparticle-based delivery vehicles offer targeted intracellular applications, influencing cellular signaling and gene expression.
  • Solid lipid nanoparticles (SLNs) are a well-established nanoparticle system with potential as drug delivery vehicles.
  • Previous work demonstrated the synthesis of ultra-small SLNs for topical delivery and biomarker detection.

Purpose of the Study:

  • To investigate the intracellular targeting capabilities of ultra-small solid lipid nanoparticles (SLNs).
  • To characterize the interactions between dye-loaded SLNs and primary human dermal fibroblasts and mouse dendritic cells.
  • To establish safe and effective dosing levels for SLN application.

Main Methods:

  • Synthesis of ultra-small, biocompatible nanoparticles using the phase inversion temperature (PIT) method.
  • Cytotoxicity assessment using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylphenyltetrazolium bromide (MTT) assay.
  • Characterization of nanoparticle-cell interactions via fluorescence microscopy and flow cytometry after exposure to dye-loaded SLNs.

Main Results:

  • Ultra-small SLNs were successfully synthesized using the PIT method.
  • MTT assays determined appropriate dosing levels for nanoparticle-cell interaction studies.
  • Fluorescence microscopy and flow cytometry confirmed particle uptake by human dermal fibroblasts and mouse dendritic cells over time.
  • No significant toxicity was observed in either cell type upon exposure to the dye-loaded SLNs.

Conclusions:

  • Ultra-small SLNs are suitable for intracellular targeting across different cell types.
  • The biocompatibility and uptake characteristics of SLNs support their use as a versatile nanoparticle delivery system.
  • This study validates the potential of SLNs for applications requiring targeted intracellular delivery.